Literature DB >> 4097282

Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout).

R G Russell, S Bisaz, H Fleisch, H L Currey, H M Rubinstein, A A Dietz, I Boussina, A Micheli, G Fallet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4097282     DOI： 10.1016/s0140-6736(70)92070-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  33 in total

1.  Interaction of polymorphonuclear leukocytes with calcium pyrophosphate dihydrate crystals deposited in chondrocalcinosis cartilage.

Authors:  H Ishikawa; Y Ueba; T Isobe; K Hirohata
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

2.  Inorganic pyrophosphate pool size and turnover rate in arthritic joints.

Authors:  M Camerlain; D J McCarty; D C Silcox; A Jung
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Familial chondrocalcinosis in the Chiloe Islands, Chile.

Authors:  A J Reginato; J L Hollander; V Martinez; F Valenzuela; V Schiapachasse; E Covarrubias; S Jacobelli; R Arinoviche; D Silcox; F Ruiz
Journal:  Ann Rheum Dis       Date:  1975-06       Impact factor: 19.103

Review 4.  Osteogenesis imperfecta: diagnosis and treatment.

Authors:  A Biggin; C F Munns
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

5.  Factors affecting the solubility of calcium pyrophosphate dihydrate crystals.

Authors:  R M Bennett; J R Lehr; D J McCarty
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

6.  Measurement of inorganic pyrophosphate in biological fluids. Elevated levels in some patients with osteoarthritis, pseudogout, acromegaly, and uremia.

Authors:  D C Silcox; D J McCarty
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

7.  Morphological study of articular cartilage in pyrophosphate arthropathy. (Chondrocalcinosis articularis or calcium pyrophosphate dihydrate crystal deposition diseases).

Authors:  A O Bjelle
Journal:  Ann Rheum Dis       Date:  1972-11       Impact factor: 19.103

8.  Bisphosphonates for the treatment of osteoporosis: insights for clinicians.

Authors:  E Michael Lewiecki
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091

9.  Formation of calcium pyrophosphate crystals in vitro: implications for calcium pyrophosphate crystal deposition disease (pseudogout).

Authors:  P R Hearn; R G Russell
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

10.  Role of phosphate, pyrophosphate, adenine nucleotides and sulfate in activating production of the superoxide radical by macrophages, and in formation of rat paw edema.

Authors:  Y Oyanagui
Journal:  Agents Actions       Date:  1977-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.